University of Michigan Rogel Cancer Center Five University of Michigan Rogel Cancer Center members were elected as 2022 fellows of the American Association for the Advancement of Science. The Rogel fellows are: Thomas Carey, PhD; Joerg Lahann, PhD; Marina Pasca di Magliano, PhD; Donna Martin, MD, PhD; and Duxin Sun, PhD. Read More

Fox Chase Cancer Center, Temple Health Fox Chase Cancer Center has achieved Magnet designation for nursing excellence from the American Nurses Credentialing Center for the sixth consecutive time. Fox Chase has held Magnet status continuously since 2000, when it became the first hospital in Pennsylvania and the first specialty hospital in the United States to achieve Magnet designation. Read More

The University of Texas MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center has been awarded 15 grants totaling $19.38 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of cancer research projects across the institution. Read More

UPMC Hillman Cancer Center The University of Pittsburgh was awarded a five-year, $11.2 million grant from the National Institutes of Health (NIH) to support a Head and Neck Cancer Specialized Program of Research Excellence (SPORE). The award will be led by Robert L. Ferris, MD, PhD, director of UPMC Hillman Cancer Center, and Heath Skinner, MD, PhD, chair and associate professor, Department of Radiation Oncology. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine Baylor College of Medicine has been awarded more than $5.8 million in grants by the Cancer Prevention & Research Institute of Texas (CPRIT) to support innovative translational research and cancer treatments. CPRIT awarded more than $90 million in grants to institutions across Texas to advance the fight against cancer, including four grants to Baylor. Read More

UK Markey Cancer Center The University of Kentucky Markey Cancer Center and UK HealthCare has received a $1.6 million gift from the Telford Foundation to establish the John R. van Nagell, Jr. Chair in Gynecologic Oncology. The donation will be matched by $800,000 from UK’s Research Challenge Trust Fund, for a total gift of $2.4 million that will support the senior level faculty position.   Read More

Huntsman Cancer Institute at the University of Utah Huntsman Cancer Foundation Chair and CEO Peter Huntsman has announced that Kim Wirthlin will be president and chief operating officer. During her 16 years of employment at the University of Utah, Wirthlin has worked as the vice president of government relations and as the chief marketing and communications officer for the university’s health care system and Health Sciences. Read More

Yale Cancer Center, Yale School of Medicine New data from a Yale Cancer Center-led clinical trial shows improved rates of survival and reduced risk of recurrence in patients taking osimertinib, a targeted therapy for non-small cell lung cancer (NSCLC). The phase III ADAURA clinical trial assessed the safety and efficacy of osimertinib in patients with surgically removed (completely resected) stage IB-IIA NSCLC, who were previously treated with or without adjuvant chemotherapy. …

Cedars-Sinai Cancer Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers – even in microscopic amounts. Their work suggests that this "liquid biopsy" test could spare many patients unnecessary treatment-related side effects, directing them instead to effective therapies that could prolong their lives. Read More

UK Markey Cancer Center A new University of Kentucky Markey Cancer Center study will help inform policy on the sale and marketing of two different tobacco products recently introduced to the U.S. market. The study is one of the first to examine the retail availability of disposable e-cigarettes and oral nicotine pouches and gives an early indication the products are targeted to different audiences.   Read More

UPMC Hillman Cancer Center Women who ovulate for longer over their lifetimes have a higher risk of developing ovarian cancer, suggesting that suppressing ovulation can lower this risk. A new international study offers new clues as to how oral contraceptives, pregnancy, and breastfeeding impact ovarian cancer risk beyond simply suppressing ovulation and how this link may vary among different ovarian cancer subtypes. Read More

University of New Mexico Comprehensive Cancer Center The UNM Comprehensive Cancer Center will soon be examining the potential for using cutting-edge radioisotope technology called 177 Lu-PSMA-617 to treat advanced prostate cancer. The center will be one of a few sites in the country participating in a clinical trial to expand the application of theranostic treatment to patients with prostate cancer. This type of treatment is currently used at the cancer center for neuroendocrine tumors. …

University of Florida Health Cancer Center University of Florida researchers have made a significant discovery in the development highly targeted chemotherapies for breast and other cancers. The scientists have spent years developing antibody-drug conjugates, or ADCs, that combine a protective protein and a cancer-killing drug. Recently published findings detail the first time a particular type of cancer-killing "payload" has been used for ADC development. Read More

Winship Cancer Institute of Emory University A large first-of-its-kind study finds that expanded Medicaid coverage under the Affordable Care Act (ACA) leads to better survival outcomes for young adults aged 18-39 newly diagnosed with cancer, particularly those identified as of Hispanic ethnicity or non-Hispanic Black race. Additionally, young adults with breast cancer and stage IV cancers had pronounced improvements attributable to ACA-expanded Medicaid.   Read More

Roswell Park Comprehensive Cancer Center Vaping cannabidiol (CBD), leads to more severe lung damage than vaping nicotine, according to a study from Roswell Park Comprehensive Cancer Center. Until now, research on the health effects of vaping, or using e-cigarettes, has focused almost exclusively on vaping nicotine as opposed to CBD.   Read More

The University of Texas MD Anderson Cancer Center Risk model-based lung cancer screening strategies, which select individuals based on personal risk, are more cost effective than current recommendations based solely on age and smoking history, according to a study led by the Cancer Intervention and Surveillance Modeling Network Lung Working Group, which includes researchers from The University of Texas MD Anderson Cancer Center. Read More

Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine The severity of immune-mediated intestinal diseases such as graft-versus-host disease or inflammatory bowel diseases is known to be associated with alterations in the gut microbiome, but what leads to such disruption has remained a mystery. Researchers at Baylor College of Medicine and collaborating institutions report that alterations in the gut microbiome are connected to an increase in the oxygen levels in the inte…

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University It is now widely understood that cancer is a disease of acquired defects in genes and gene function. A recently published article addresses new quantitative approaches to better define and measure these defects in gene function, known as epigenetics, and their interplay with the genetic landscape of cancer. Read More

UCLA Jonsson Comprehensive Cancer Center A new clinical and preclinical study from UCLA Jonsson Comprehensive Cancer Center identifies the DNA roots of resistance to targeted cancer therapy, providing a possible strategy to address a vexing issue in cancer therapeutics. To understand how the cancer genome changes immediately after the initiation of targeted therapy—potentially generating new genetic variants capable of escaping the therapy—the researchers focused on metastatic cutaneous …

Rutgers Cancer Institute of New Jersey Investigators from Rutgers Cancer Institute of New Jersey, together with RWJBarnabas Health, found that a higher risk of mortality in Black breast cancer survivors is associated with a history of cigarette smoking along with regular alcohol consumption at the time of diagnosis. Read More

Roswell Park Comprehensive Cancer Center Investigators from Roswell Park Comprehensive Cancer Center were among the experts whose work was highlighted at the 2023 Tandem Transplantation & Cellular Therapy Meetings of the American Society for Transplantation and Cellular Therapy and Center for International Blood and Marrow Transplant Research. Read More

Winship Cancer Institute of Emory University In a retrospective study, a team of researchers from several health care systems and universities, including Emory University, has discovered a new artificial intelligence (AI)-derived biomarker that uses routine imaging scans to help predict which patients with lung cancer will respond to immunotherapy.    Read More

Vanderbilt-Ingram Cancer Center A research team at Vanderbilt University Medical Center has detailed a stepwise method for analyzing large data sets (more than 550,000 individuals) that can improve dramatically the accuracy of "clonal hematopoiesis of indeterminate potential,” or CHIP, determination. Read More

University of Michigan Rogel Cancer Center The protein STAT5 has long been an appealing target against cancer, but after decades of research it was consigned to the "undruggable" category. Now, University of Michigan Rogel Cancer Center researchers have found success with a new approach. Read More

Siteman Cancer Center Researchers at Washington University School of Medicine in St. Louis have discovered that the difference between people who do and do not respond to immunotherapy may have to do with an immune cell known as CD5+ dendritic cells because they bear the protein CD5 on their outer surfaces. Read More

Hollings Cancer Center, Medical University of South Carolina A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development, new research at MUSC Hollings Cancer Center shows. This new data is the first to show the cellular origin of normal pancreatic fibroblasts and cancer-associated fibroblasts that influence tumor progression. Read More

University of Florida Health Cancer Center A study led by UF Health Cancer Center researchers found that Black and Hispanic adults had less knowledge and were less likely to undergo cancer genetic testing than white adults. The researchers compared self-reported cancer genetic testing knowledge and use by race and ethnicity. They also looked at the perceived importance of genetic information for cancer care in relation to the uptake of cancer genetic testing. Read More

UCSF Helen Diller Family Comprehensive Cancer Center A UC San Francisco breast cancer screening study is expanding to reach women as young as 30, with the aim of adding thousands of women who could be at higher risk of developing aggressive cancer. Known as WISDOM 2.0, the study is testing a personalized approach that replaces the standard annual mammogram with recommended screening schedules based on personal risk factors, such as age, genetics, lifestyle, health history and breast dens…

Yale Cancer Center, Yale School of Medicine Age-based heuristics, or "rules of thumb," can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records. Read More

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute Pending approval by The Ohio State University Board of Trustees, a new interdisciplinary research facility in the university’s Carmenton innovation district will be named Pelotonia Research Center. The naming is in recognition of Pelotonia’s philanthropic support for cancer research at OSUCCC–James. Read More